ZA200708895B - Treatment of liver diseases in which iron plays a role in pathogenesis - Google Patents
Treatment of liver diseases in which iron plays a role in pathogenesisInfo
- Publication number
- ZA200708895B ZA200708895B ZA200708895A ZA200708895A ZA200708895B ZA 200708895 B ZA200708895 B ZA 200708895B ZA 200708895 A ZA200708895 A ZA 200708895A ZA 200708895 A ZA200708895 A ZA 200708895A ZA 200708895 B ZA200708895 B ZA 200708895B
- Authority
- ZA
- South Africa
- Prior art keywords
- pathogenesis
- role
- treatment
- liver diseases
- iron plays
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68584805P | 2005-05-31 | 2005-05-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200708895B true ZA200708895B (en) | 2008-10-29 |
Family
ID=39405969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200708895A ZA200708895B (en) | 2005-05-31 | 2007-10-17 | Treatment of liver diseases in which iron plays a role in pathogenesis |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101180053A (en) |
UA (1) | UA92912C2 (en) |
ZA (1) | ZA200708895B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114073772A (en) * | 2020-08-18 | 2022-02-22 | 上海市公共卫生临床中心 | Use of an iron chelator for the treatment or prevention of polyoma viral infections |
-
2006
- 2006-05-30 CN CNA2006800176178A patent/CN101180053A/en active Pending
- 2006-05-30 UA UAA200713361A patent/UA92912C2/en unknown
-
2007
- 2007-10-17 ZA ZA200708895A patent/ZA200708895B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101180053A (en) | 2008-05-14 |
UA92912C2 (en) | 2010-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL187000A0 (en) | Treatment of liver diseases in which iron plays a role in pathogenesis | |
EP1962961A4 (en) | Demibodies: dimerisation-activated therapeutic agents | |
EP1948298A4 (en) | Bio-interventional therapeutic treatments for cardiovascular diseases | |
GB0506147D0 (en) | Therapeutic agents | |
GB0525680D0 (en) | Therapeutic compositions | |
GB0518237D0 (en) | Therapeutic compounds | |
GB0509326D0 (en) | Therapeutic compounds | |
GB0509573D0 (en) | Therapeutic compounds | |
IL186989A0 (en) | Therapeutic compositions | |
GB0518361D0 (en) | Therapeutic compounds | |
GB0519797D0 (en) | Therapeutic agents | |
GB0505437D0 (en) | Therapeutic agents | |
GB0505725D0 (en) | Therapeutic agents | |
GB0509405D0 (en) | Therapeutic compounds | |
GB0519350D0 (en) | Therapeutic agents | |
GB0518819D0 (en) | Therapeutic agents | |
GB0518817D0 (en) | Therapeutic agents | |
GB0513747D0 (en) | Therapeutic compounds | |
EP1885384A4 (en) | Treating liver diseases | |
GB0516661D0 (en) | Therapeutic agents | |
GB0514738D0 (en) | Therapeutic agents | |
SI1890705T1 (en) | Use of 24-nor-UDCA for the treatment of cholestatic liver diseases | |
GB0518235D0 (en) | Therapeutic compounds | |
ZA200708895B (en) | Treatment of liver diseases in which iron plays a role in pathogenesis | |
GB0523998D0 (en) | Therapeutic agents |